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Abstract
Objectives This study assessed the awareness and use of
traditional and novel tobacco products and dual use of
cigarettes with electronic nicotine delivery systems
(ENDS) among USA adults.
Methods Data were obtained from the 2014 Tobacco
Products and Risk Perceptions Survey of a probability
sample of 5717 USA adults conducted June–November,
2014.
Results Use of ENDS varied by demography and by
cigarette and other tobacco use. Adults aged 25–34, non-
heterosexual adults, and those reporting poorer health
reported higher rates of current ENDS use. Current cigar-
ette smokers had much greater odds of ENDS ever use than
never smokers, with one-half of all cigarette smokers
having used ENDS and 20.7 % currently using them.
However, 22.0 % of current ENDS users were former
cigarette smokers, and 10.0 % were never cigarette
smokers.
Conclusions Patterns of ENDS use are evolving rapidly
and merit continued surveillance. Nearly 10 % of adult
ENDS usage is among never smokers. The public health
challenge is how to enhance the potential that ENDS can
replace combusted tobacco products without expanding
nicotine use among youth, long-term ex-smokers, and other
vulnerable populations.
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Introduction
The USA appears to be entering a period of dramatic
transformation of the types of tobacco products com-
monly used in the USA, potentially as dramatic as when
the ‘‘modern’’ cigarette replaced the cigar and chewing
tobacco 100 years ago, and when the filtered and ‘‘low-
tar’’ cigarette transformed the market 40–60 years ago
(US Department of Health and Human Services 2014).
The latter transformation was driven by the increased
knowledge of the health risks of cigarettes (e.g., 1964
Surgeon General Report) but produced a shift in product
that did not reduce population harm and increased indi-
vidual risk for some tobacco-related diseases such as
adenocarcinoma of the lung (US Department of Health
and Human Services 2014). As societal knowledge about
the harm caused by traditional cigarettes has continued to
increase, the number and type of tobacco and nicotine
products available to consumers have increased
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dramatically in recent years. The current array of novel
and alternative products includes non-combustible,
smokeless, spit-less tobacco products such as snus and
dissolvables, which differ in form from conventional
chewing tobacco (Bahreinifar et al. 2013; Seidenberg
et al. 2012); little cigars and cigarillos (LCCs), which
differ from their larger, conventional cigar counterparts;
water pipes or hookahs; and an increasing variety of
electronic vapor products (ENDS), known most com-
monly as e-cigarettes (Agaku and Alpert 2015; Agaku
et al. 2014; McMillen et al. 2014). ENDS vary widely in
appearance and functionality, but all are battery-powered
and can deliver combinations of nicotine and other addi-
tives in an aerosol (Knorst et al. 2014; Orellana-Barrios
et al. 2015).
Awareness of many of these novel and alternative
products appears to be significant and rising steadily
among adults in the USA (Choi and Forster 2013; King
et al. 2015). Studies conducted on the prevalence of use for
these products indicate some volatility in popularity of the
newer smokeless products (Biener et al. 2014; Zhu et al.
2013) but substantial and rising prevalence rates for little
cigars and cigarillos among certain subgroups (Cohn et al.
2015; Corey et al. 2014; Messer et al. 2015; Richardson
et al. 2013), hookahs (Brockman et al. 2012; Villanti et al.
2015), and, especially, for ENDS (Agaku et al. 2014;
Carroll Chapman and Wu 2014; King et al. 2015;
McMillen et al. 2014; Pepper and Brewer 2014).
High rates of smoking-attributable disease and death,
and the associated health and societal costs, have been
predicted to persist for decades into the 21st century (US
Department of Health and Human Services 2014). These
disturbing predictions have prompted some to encourage
this current pattern of tobacco product transformation,
hoping that the novel products could develop into a much
lower risk ‘‘disruptive technology’’ that replaces the most
lethal forms of nicotine delivery: the cigarette and the other
inhalable combusted products (Abrams 2014; Cobb and
Abrams 2014; Fagerstrom and Bridgman 2014; West and
Brown 2014). However, others have raised cautions about
how these new products could produce harms to population
health (Chapman 2015; Chen and Husten 2014; England
et al. 2015; Grana et al. 2014; Schraufnagel et al. 2014).
As of October, 2015, the Food and Drug Administration
lacks the authority to regulate several novel tobacco
products, notably ENDS marketed for non-therapeutic
purposes (Chen and Husten 2014). Despite meeting the
definition of a ‘‘tobacco product’’ under the Family
Smoking Prevention and Tobacco Control Act (FSPTCA),
the act only granted the FDA immediate authority over
cigarettes, smokeless tobacco, and roll-your-own tobacco
(Chen and Husten 2014). However, the FSPTCA allows the
FDA to promulgate regulations extending regulatory
authority over all other products meeting the definition of
tobacco product (Lindblom 2015). The FDA needs current
information on rates and trends of use of these products to
guide and support its rule making and regulatory actions
(or lack thereof).
In summary, the public health challenge is how to bal-
ance the public health messaging about these alternative
and novel tobacco products and to enhance the potential
that they can become a ‘‘disruptive technology’’ replacing
the combusted tobacco products without expanding the
patterns of nicotine use among youth and young adults,
long-term ex-smokers, and other vulnerable populations.
Information on how these alternative and novel tobacco
products are being used is critically needed as the mar-
keting and use of these products are rapidly increasing
(Emery et al. 2014; Pepper et al. 2015). To address these
needs, data from the 2014 Tobacco Products and Risk
Perceptions Survey are presented here assessing the
awareness and use of ENDS and other novel or alternative
tobacco products among USA adults, demographic pre-
dictors of use, and dual use of combusted tobacco products
and ENDS. We are not aware of any other published
prevalence estimates of USA adult ENDS use from 2014.
Together, these results will help inform public health and




We obtained data for this study from the 2014 Tobacco
Products and Risk Perceptions Survey conducted by the
Georgia State University Tobacco Center of Regulatory
Science (TCORS). This survey is an annual, cross-sectional
survey of a probability sample drawn from Gfk’s Knowl-
edgePanel, a probability-based web panel designed to be
representative of non-institutionalized USA adults. Only
adults sampled via address-based sampling or random digit
dialing (previous) are eligible to join KnowledgePanel.
Recruited panelists without internet access are provided a
computer with internet access. Information from the profile
survey is used to calculate a panel demographic post-
stratification weight to adjust for sources of sampling and
non-sampling error, such as panel recruitment non-re-
sponse and panel attrition. Data collection occurred June–
November, 2014. Participants completed the main survey
in 23 min (median) and received a cash-equivalent of $5
for their participation. This study was approved by the
Georgia State University Institutional Review Board.
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Sample
A probability sample of USA adults from KnowledgePanel
and a representative oversample of pre-identified cigarette
smokers were selected with probabilities proportional to
size (PPS) after application of the panel demographic post-
stratification weight. Overall, we invited 7991 Knowl-
edgePanel members to participate in the survey: 7061
members for the general population sample, of which
74.3 % completed the screener survey and qualified for the
main survey; and 930 members for the smoker augment
sample, of which 697 completed the screener and 599
(74.9 %) qualified for the main survey by confirming their
current smoking status. Of 5833 qualified completers, 116
cases were excluded due to refusing to answer more than
one-half of the survey questions, yielding an analytic
sample of 5717 cases. A final stage completion rate of
74.4 % and a qualification rate of 98.2 % were obtained.
The average panel recruitment rate for this study, reported
by GfK, was 13.7 % and the average profile rate was
65.3 %, for a cumulative response rate of 6.6 %. Following
closure of the main survey field period, a study-specific
post-stratification weight was computed using an iterative
proportional fitting (raking) procedure to adjust for survey
non-response as well as for oversampling of smokers.
Demographic and geographic distributions from the most
recent Current Population Survey (CPS) were employed as
benchmarks for adjustment, and included gender, age, race/
ethnicity, education, household income, census region,
metropolitan area, and internet access.
Measures
Smoking status
Respondents that reported not having smoked at least 100
cigarettes in their lives were classified as never (estab-
lished) smokers. Those respondents who reported smoking
at least 100 cigarettes in their lives were asked, ‘‘Do you
currently smoke cigarettes every day, some days, or not at
all?’’ They were classified as current smokers if they
reported currently smoking cigarettes ‘‘every day’’ or
‘‘some days’’ and as former smokers if they reported ‘‘not
at all’’. Recent former smokers were defined as former
smokers who reported the last time they smoked a cigar-
ette, even one or two puffs, was within the past 5 years, and
non-recent former smokers were defined as former smokers
who last smoked a cigarette more than 5 years ago.
Awareness and use of ENDS and other tobacco products
Awareness and use of ENDS and other tobacco products
(namely, chewing tobacco, snuff, or dip; large, premium
cigars; LCCs; snus; dissolvables; and hookahs) were
assessed by asking respondents if they had heard of the
product before taking the survey and, if so, whether they
had ever tried the product, even just one time. Those
respondents who indicated they have tried one or more of
the products were asked whether they had used the prod-
ucts at least once during the past 30 days. Current users of
these products were defined as those who had used the
product at least once during the past 30 days. For some
analyses, ever (non-current) users were defined as those
who reported ever use of the product but no use in the past
30 days.
Prior to the questions assessing awareness and use of
these products, respondents were shown descriptions and
images of ENDS and LCCs. The description for ENDS
used ‘‘e-cigarette’’ and referred broadly to electronic
nicotine delivery systems. The description provided for
LCCs characterized them as smaller than traditional cigars,
usually brown, and listed several common brands.
Respondent characteristics
Demographic and other respondent characteristics data
were obtained from profile surveys administered by GfK to
KnowledgePanel panelists. Respondent characteristic
included sex, age, race/ethnicity, educational attainment,
annual household income, USA Census region, perceived
health status, sexual orientation, and presence of a child in
the home.
Statistical analysis
We used Stata/MP (v.13.1) to obtain design-based
(weighted) point estimates and 95 % confidence intervals
for awareness and use of ENDS, combustible, and non-
combustible tobacco products. Associations among vari-
ables were tested using weighted logistic regression models
and Rao–Scott v2 tests (Rao and Scott 1981). Prior to
conducting these analyses, we assessed the extent and
ignorability of missing data for ever use and past 30-day
use questions for the tobacco products. Pearson Chi-square
tests of the missing completely at random (MCAR) (Fuchs
1982) assumption were conducted using Mplus (v.7.3) and
were non-significant (ps[ 0.99). As an additional check,
full information maximum likelihood estimates of the
weighted proportions of using each product under the
missing at random (MAR) assumption were compared to
the corresponding MCAR estimates. Differences in esti-
mates were less than 0.5 %. On the bases of these checks,
respondents with missing data were excluded from further
analyses under the supported assumption that missingness
is ignorable and completely at random. (See supplemental
document for an expanded summary of the missing data.)
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Results
Table 1 reports awareness, ever use, and current use of
ENDS and other novel and alternative tobacco products
overall and by cigarette smoking status. Table 2 reports
ever and current use of ENDS and current smoking by
demography. Table 3 reports the adjusted associations
between cigarette smoking status, other combustible
tobacco use, and other non-combustible tobacco use with
ENDS use. A detailed summary of the sample and refer-
ence population demographics and ENDS use by
demography for emerging adults (18–24 years) and adults
over 25 years old can be found in the supplemental
document.
Awareness and use of electronic nicotine delivery
systems (ENDS)
Overall, 91.9 % of USA adults had heard of ENDS. Our
study estimated 14.9 % of USA adults have ever used
ENDS and 4.9 % were current users. Use was substantially
higher among current cigarette smokers compared to
Table 1 Awareness and use of electronic nicotine delivery systems (ENDS) and other tobacco products by cigarette smoking status among USA
adults, 2014
Tobacco products N Overall Cigarette smoking status
Current smoker Former smoker Never smoker
% (95 % CI) % (95 % CI) % (95 % CI) % (95 % CI)
Electronic nicotine
delivery systems
Awareness 5629 91.9 (91.0, 92.7) 89.9 (87.5, 91.8) 91.9 (90.2, 93.4) 92.5 (91.3, 93.6)
Ever use** 5085 14.9 (13.9, 16.0) 51.1 (47.8, 54.4) 13.1 (11.3, 15.2) 4.7 (3.8, 5.8)
Past 30-day use** 5008 4.9 (4.3, 5.5) 20.7 (18.1, 23.6) 3.8 (2.8, 5.1) 0.9 (0.5, 1.5)
Combustible tobacco
Little cigars/cigarillos
Awareness** 5629 87.3 (86.2, 88.3) 88.7 (86.2, 90.7) 92.5 (90.8, 93.9) 84.2 (82.6, 85.8)
Ever use** 5111 30.6 (29.2, 32.0) 46.8 (43.5, 50.1) 48.5 (45.7, 51.2) 16.5 (15.0, 18.1)
Past 30-day use** 5090 2.8 (2.3, 3.4) 9.4 (7.5, 11.8) 2.1 (1.4, 3.1) 1.2 (0.8, 2.0)
Hookah
Awareness 5629 81.4 (80.2, 82.5) 83.8 (81.2, 86.1) 80.8 (78.5, 82.9) 80.9 (79.2, 82.5)
Ever use** 5155 13.3 (12.3, 14.4) 21.0 (18.4, 23.8) 16.0 (14.1, 18.1) 9.6 (8.3,11.0)
Past 30-day use 5143 1.2 (0.9, 1.6) 2.0 (1.2, 3.4) 1.0 (0.5, 1.8) 1.0 (0.6, 1.7)
Large cigars
Awareness* 5629 90.5 (89.5, 91.4) 88.3 (85.8, 90.3) 92.8 (91.1, 94.2) 90.0 (88.6, 91.3)
Ever use** 5120 26.0 (24.7, 27.3) 30.9 (28.0, 33.9) 41.2 (38.5, 43.9) 16.4 (15.0, 18.0)
Past 30-day use 5088 1.8 (1.4, 2.2) 2.7 (1.8, 3.9) 2.0 (1.3, 2.9) 1.4 (1.0, 2.0)
Non-combustible tobacco
Smokeless tobacco
Awareness** 5629 93.8 (92.9, 94.5) 90.7 (88.5, 92.3) 95.2 (93.7, 96.3) 94.0 (92.8, 95.0)
Ever use** 5078 17.9 (16.8, 19.0) 25.3 (22.6, 28.2) 27.4 (25.0, 29.9) 10.6 (9.4, 11.9)
Past 30-day use* 5054 2.1 (1.7, 2.6) 3.5 (2.4, 5.1) 2.4 (1.6, 3.6) 1.4 (1.0, 2.0)
Snus
Awareness** 5629 59.7 (58.3, 61.1) 80.5 (77.9, 82.9) 58.5 (55.8, 61.1) 54.1 (52.1, 56.2)
Ever use** 5296 4.0 (3.5, 4.7) 11.1 (9.2, 13.4) 5.2 (4.1, 6.6) 1.4 (1.0, 2.0)
Past 30-day use** 5295 0.3 (0.2, 0.6) 1.2 (0.5, 2.8) 0.3 (0.1, 0.9) 0.0 (0, 0.2)
Dissolvables
Awareness** 5629 40.6 (39.2, 42.0) 57.8 (54.7, 60.9) 39.3 (36.7, 42.0) 36.1 (34.2, 38.0)
Ever use** 5387 1.1 (0.8, 1.4) 3.3 (2.3, 4.6) 1.0 (0.6, 1.7) 0.5 (0.3, 1.0)
Past 30-day use – – – –
% = weighted overall and column percentages. There were not sufficient data to obtain reliable estimates of past 30-day use of dissolvables
N unweighted counts, CI confidence interval
* p\ 0.01, ** p\ 0.001 (Rao–Scott v2)
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Table 2 Estimated percentage of use of electronic nicotine delivery systems (ENDS) and of cigarettes among USA adults, 2014
Demographic
characteristics
Overall ENDS Cigarette-current use
Total (N = 5717) Ever use Current use
% (95 % CI) % (95 % CI) % (95 % CI) % (95 % CI)
Overall – 14.9 (13.9, 16.0) 4.9 (4.3, 5.5) 16.6 (15.6, 17.6)
Sex p = 0.22 p = 0.20 p = 0.015
Male 48.1 (46.7, 49.6) 15.6 (14.1, 17.2) 5.3 (4.4, 6.3) 17.8 (16.4, 19.4)
Female 51.9 (50.4, 53.3) 14.2 (12.9, 15.8) 4.5 (3.7, 5.4) 15.4 (14.1, 16.7)
Age (years) p < 0.001 p < 0.001 p < 0.001
18–24 12.6 (11.5, 13.8) 19.9 (16.1, 24.2) 5.2 (3.4, 7.9) 13.6 (10.9, 16.9)
25–34 16.3 (15.2, 17.4) 23.3 (20.1, 26.7) 8.6 (6.6, 11.0) 20.7 (18.1, 23.7)
35–44 18.1 (16.9, 19.2) 16.2 (13.8, 18.9) 5.1 (3.8, 6.8) 18.9 (16.4, 21.7)
45–54 16.4 (15.4, 17.5) 15.1 (12.9, 17.6) 4.8 (3.6, 6.3) 21.4 (19.0, 24.0)
55–64 18.9 (17.9, 20.0) 11.3 (9.6, 13.2) 4.0 (3.0, 5.2) 16.3 (14.5, 18.4)
65? 17.7 (16.8, 18.8) 6.3 (5.0, 8.0) 2.2 (1.5, 3.2) 8.3 (6.9, 9.8)
Race/ethnicity p = 0.62 p = 0.81 p < 0.001
White, NH 66.0 (64.5, 67.5) 15.0 (13.9, 16.3) 4.8 (4.1, 5.5) 15.2 (14.2, 16.3)
Black, NH 11.6 (10.6, 12.6) 12.8 (10.2, 16.0) 4.5 (3.0, 6.6) 26.7 (23.1, 30.7)
Hispanic 15.0 (13.8, 16.2) 15.3 (12.2, 19.0) 5.2 (3.5, 7.8) 15.9 (13.2, 19.1)
Other, NH 7.5 (6.7, 8.4) 16.1 (11.8, 21.5) 5.9 (3.6, 9.6) 14.1 (10.9, 18.1)
Education p < 0.001 p = 0.003 p < 0.001
\High school 12.6 (11.4, 13.8) 19.5 (15.8, 23.7) 6.4 (4.5, 9.1) 28.8 (24.7, 33.3)
High school 29.6 (28.3, 30.9) 15.2 (13.4, 17.3) 5.1 (4.1, 6.4) 20.2 (18.3, 22.2)
Some college 28.9 (27.7, 30.2) 19.2 (17.2, 21.4) 5.8 (4.7, 7.1) 18.3 (16.6, 20.1)
College degree? 28.9 (27.7, 30.2) 8.4 (7.1, 9.8) 3.1 (2.4, 4.1) 5.8 (4.9, 6.8)
Household income p < 0.001 p < 0.001 p < 0.001
\$15 K 11.4 (10.4, 12.4) 23.4 (19.6, 27.6) 8.2 (6.0, 11.2) 37.0 (32.8, 41.4)
$15 K–$24.9 K 7.1 (6.4, 7.9) 16.3 (12.8, 20.4) 5.8 (3.8, 8.7) 24.5 (20.4, 29.2)
$25 K–$39.9 K 15.5 (14.4, 16.6) 15.7 (13.1, 18.6) 5.6 (4.2, 7.5) 21.4 (18.7, 34.4)
$40 K–$59.9 K 16.2 (15.2, 17.3) 15.5 (13.1, 18.2) 5.2 (3.8, 7.0) 17.4 (15.2, 19.8)
$60 K–$84.9 K 16.6 (15.6, 17.7) 14.7 (12.3, 17.5) 4.8 (3.5, 6.6) 12.2 (10.3, 14.3)
$85 K–$99.9 K 6.8 (6.1, 7.6) 18.4 (14.2, 23.5) 6.5 (4.1, 10.0) 11.7 (8.9, 15.3)
$100 K? 26.4 (25.1, 27.6) 9.3 (7.9, 11.1) 2.3 (1.7, 3.2) 6.3 (5.3, 7.5)
USA region p = 0.56 p = 0.24 p = 0.010
Northeast 18.2 (17.1, 19.3) 15.0 (12.6, 17.8) 4.1 (2.9, 5.8) 17.0 (14.7, 19.5)
Midwest 21.4 (20.3, 22.5) 14.2 (12.4, 16.3) 4.5 (3.4, 5.9) 17.1 (15.3, 19.1)
South 37.1 (35.7, 38.5) 14.4 (12.8, 16.2) 4.8 (3.9, 5.8) 17.9 (16.3, 19.7)
West 23.4 (22.1, 24.7) 16.2 (14.0, 18.8) 6.0 (4.7, 7.7) 13.6 (11.8, 15.7)
Perceived health status p < 0.001 p < 0.001 p < 0.001
Excellent 11.5 (10.6, 12.5) 9.7 (7.2, 13.0) 2.1 (1.2, 3.9) 8.7 (6.6, 11.6)
Very good 36.3 (34.9, 37.7) 12.5 (11.0, 14.3) 4.1 (3.2, 5.1) 12.3 (10.9, 13.8)
Good 38.0 (36.6, 39.4) 15.9 (14.2, 17.7) 5.1 (4.2, 6.2) 20.2 (18.5, 22.1)
Fair 12.0 (11.0, 13.0) 21.5 (18.1, 25.4) 8.6 (6.4, 11.5) 25.6 (22.2, 29.3)
Poor 2.2 (1.8, 2.7) 26.9 (18.8, 36.9) 10.1 (5.5, 17.7) 39.4 (30.7, 48.9)
Sexual orientation p < 0.001 p = 0.10 p = 0.004
Heterosexual 94.5 (93.7, 95.1) 14.4 (13.3, 15.5) 4.8 (4.2, 5.4) 18.6 (15.2, 17.2)
Gay/lesbian/bisexual/other 5.5 (4.9, 6.3) 24.1 (19.2, 29.8) 6.7 (4.5, 9.9) 22.8 (18.2, 28.0)
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former and never smokers. Among current cigarette
smokers, the odds of ever (OR = 21.4, 95 % CI = 16.5,
27.8) and current use (OR = 29.7, 95 % CI = 17.3, 51.0)
of ENDS were substantially higher than for never smokers.
Of those who have ever tried ENDS, 57.7 % (95 %
CI = 53.7, 61.5) were current cigarette smokers, 25.3 %
(95 % CI = 22.0, 28.9) were former smokers, and 17.0 %
(95 % CI = 14.0, 20.6) were never smokers.
Ever and current use of ENDS is highest among young
adults, particularly 25–34 year olds; those with some col-
lege education; those with less than a high school
educational attainment; those with only fair or poor per-
ceived health; and those with a non-heterosexual
orientation. Young adults (25–34 years old) were more
likely (OR = 1.7, 95 % CI = 1.0, 2.9) and those with a
college degree were less likely (OR = 0.5, 95 % CI = 0.3,
0.7) to be current ENDS users. Adults with incomes
between $40,000 and $60,000, $60,000 and $85,000, and
greater than $100,000 had lower odds of current ENDS use
(ORs = 0.3–0.6). Current ENDS use was less likely among
those reporting good or better perceived physical health
(OR = 0.5, 95 % CI = 0.3, 0.6), although this association
was non-significant when controlling for cigarette smoking
(AOR = 0.72, 95 % CI = 0.49, 1.05). Sex, race/ethnicity,
presence of children in the home, and USA Census region
were not associated with ENDS use in bivariate analyses.
Sexual orientation was not associated with current ENDS
use, though an association was observed for ever use. Non-
heterosexual adults had higher odds (OR = 1.9, 95 %
CI = 1.4, 2.6) of ever using ENDS. This association
remained significant when controlling for smoking status
(AOR = 1.8, 95 % CI = 1.2, 2.6).
Awareness and use of other tobacco products
In 2014, an estimated 16.6 % (95 % CI = 15.6, 17.6) of
USA adults were current cigarette smokers and 27.6 %
(95 % CI = 26.3, 28.9) were former cigarette smokers. We
observed high awareness of other combustible tobacco
products (Table 1), and nearly two-thirds (62.3 %, 95 %
CI = 60.9, 63.8) of USA adults were ever users and
21.6 % (95 % CI = 20.4, 22.8) were current users of any
combustible tobacco product. Use of these other com-
bustible products varied by cigarette smoking status.
Nearly one-third of all respondents reported ever using
LCCs. Ever use of LCCs was more likely among current or
former cigarette smokers, and current users were more
likely to be current cigarette smokers. More than one in ten
respondents has ever used hookahs, with use being higher
among current and former cigarette smokers. Few adults
reported current hookah use (1.2 %). Approximately one-
quarter of respondents have ever smoked large cigars, with
ever use being more common among former cigarette
smokers. Current use of large cigars was reported by few
adults (1.8 %). Whereas USA adults reported very high
awareness of traditional smokeless tobacco (93.8 %), their
awareness of snus and dissolvables was comparatively low
(59.7 and 40.6 %, respectively). Nearly one-fifth of USA
adults (17.9 %) have ever used traditional smokeless
tobacco, and 2.1 % are current users. Snus use was less
prevalent, with 4.0 % reporting ever use and only 0.3 %
reporting current use. Dissolvables were the least prevalent
non-combustible tobacco product examined in this study;
only 1.1 % of USA adults reported ever using the product.
Current use of dissolvables was too low to obtain reliable
estimates with our sample. Non-combustible tobacco use
was more prevalent among current and former cigarette
smokers compared to never smokers. Current cigarette
smokers (OR = 2.9, 95 % CI = 2.3, 3.5) and former
smokers (OR = 3.2, 95 % CI = 2.7, 3.8) were more likely
to ever use traditional smokeless tobacco than never
smokers. Current smokeless tobacco use was greater
among current cigarette smokers (OR = 2.5, 95 %
CI = 1.5, 4.2) and former smokers (OR = 1.7, 95 %
CI = 1.0, 2.9). Regarding snus, ever use was several times
greater among current cigarette smokers (OR = 9.0, 95 %
CI = 5.9, 13.8) and former smokers (OR = 3.9, 95 %




Overall ENDS Cigarette-current use
Total (N = 5717) Ever use Current use
% (95 % CI) % (95 % CI) % (95 % CI) % (95 % CI)
Presence of children under
18 in the household
p = 0.083 p = 0.092 p = 0.74
Yes 31.7 (30.3, 33.1) 16.3 (14.4, 18.5) 5.7 (4.5, 7.1) 16.8 (15.1, 18.7)
No 68.3 (66.9, 69.7) 14.3 (13.1, 15.5) 4.5 (3.9, 5.3) 16.5 (15.3, 17.7)
Current use of ENDS was defined as any use in the past 30 days. Boldface indicates statistical significance (p\ 0.05)
NH non-Hispanic, CI confidence interval, RSE relative standard error
 30 % B RSE B 49 %
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Table 3 Associations between combustible and other non-combustible tobacco use and use of electronic nicotine delivery systems (ENDS)
among USA adults, 2014
Model predictors ENDS ever use ENDS current use
Model 1 Model 2 Model 1 Model 2
AOR (95 % CI) AOR (95 % CI) AOR (95 % CI) AOR (95 % CI)
Tobacco use
Cigarette smoking status
Current smokers 17.9*** (13.8, 23.3) 25.0*** (18.4, 34.0) 22.8*** (13.1, 39.9) 28.1*** (15.9, 49.4)
Former smokers 1.9*** (1.4, 2.6) 3.0*** (2.1, 4.2) 3.5*** (1.9, 6.5) 4.6*** (2.4, 8.6)
Never smokers Ref Ref Ref Ref
Other combustible product use
Ever use 3.9*** (3.0, 5.0) 3.9*** (3.0, 5.1) – –
Never use Ref Ref – –
Current use – – 4.4*** (2.5, 7.7) 4.3*** (2.4, 7.9)
Ever (not current) use – – 1.8** (1.3, 2.6) 1.5* (1.0, 2.2)
Never use – – Ref Ref
Non-combustible product use
Ever use 1.5** (1.2, 1.9) 1.6*** (1.2, 2.1) – –
Never use Ref Ref – –
Current use – – 1.9 (1.0, 3.7) 1.5 (0.7, 3.1)
Ever (non-current) use – – 1.1 (0.8, 1.6) 1.2 (0.8, 1.8)




Male – Ref – Ref
Female – 1.9*** (1.5, 2.3) – 1.3 (0.9, 1.8)
Age (years)
18–24 – Ref – Ref
25–34 – 0.7 (0.4, 1.1) – 0.9 (0.5, 1.7)
35–44 – 0.4*** (0.2, 0.6) – 0.5* (0.2, 0.9)
45–54 – 0.3*** (0.2, 0.4) – 0.4** (0.2, 0.7)
55–64 – 0.2*** (0.1, 0.3) – 0.4* (0.2, 0.8)
65? – 0.1*** (0.1, 0.2) – 0.3** (0.1, 0.6)
Race/ethnicity
White, NH – Ref – Ref
Black, NH – 0.5** (0.3, 0.8) – 0.6 (0.3, 1.1)
Hispanic – 1.0 (0.7, 1.5) – 1.1 (0.6, 1.8)
Other, NH – 1.0 (0.6, 1.6) – 1.2 (0.7, 2.3)
Education
\High school – Ref – Ref
High school – 1.0 (0.7, 1.5) – 1.2 (0.7, 2.1)
Some college – 1.3 (0.9, 2.0) – 1.4 (0.8, 2.4)
College degree ? – 0.8 (0.5, 1.2) – 1.6 (0.9, 3.1)
Household income
\$15 K – Ref – Ref
$15 K–$24.9 K – 1.1 (0.6, 1.9) – 1.3 (0.6, 2.6)
$25 K–$39.9 K – 1.1 (0.7, 1.7) – 1.3 (0.7, 2.1)
$40 K–$59.9 K – 1.3 (0.9, 2.0) – 1.3 (0.8, 2.3)
$60 K–$84.9 K – 1.4 (0.9, 2.1) – 1.3 (0.7, 2.5)
$85 K–$99.9 K – 2.0** (1.2, 3.2) – 2.1* (1.0, 4.5)
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with smoking status were observed for current use of snus
use and ever use of dissolvables.
Associations between ENDS use and other tobacco use
Adjusting for other tobacco use, current smokers had
nearly 18 times greater odds of ever use of ENDS and
nearly 23 times the odds of current use of ENDS than did
never smokers (Table 3, Model 1). Former smokers had
twice the odds of ever ENDS use and 3.5 times the odds
of current ENDS use as never smokers. These associa-
tions held and, in fact, were stronger, when statistically
controlling for demographic and health status differences
(Model 2). Other combustible and non-combustible use
was also predictive of ENDS use. Ever use of any other
combustible tobacco products (namely, LCCs, large
cigars, and hookahs) was associated with 3.9 times greater
odds of ever ENDS use than never use of these other
combustible products. Ever users of non-combustible
tobacco products (namely, smokeless tobacco, snus, and
dissolvables) had 1.5 times greater odds of ever ENDS
use than never users of these non-combustible tobacco
products. Other combustible tobacco use was also pre-
dictive of current ENDS use. Adjusting for smoking status
and non-combustible tobacco use, current users of non-
combustible tobacco products had 4.4 times the odds and
former use was associated with 1.8 times greater odds of
current ENDS use than never users of these alternative
combustible products. There was no statistically signifi-
cant association between non-combustible tobacco
product use and current ENDs use. These patterns of
findings also remained and effect sizes undiminished after
statistical adjustments were made for the demographic
and health status covariates. After adjusting for other
tobacco use and other covariates, sex, age, race/ethnicity,
income, USA region, and perceived health status were
significantly associated with ever use of ENDS and/or
with current use of ENDS.
Table 3 continued
Model predictors ENDS ever use ENDS current use
Model 1 Model 2 Model 1 Model 2
AOR (95 % CI) AOR (95 % CI) AOR (95 % CI) AOR (95 % CI)
$100 K? – 1.1 (0.7, 1.7) – 0.9 (0.5, 1.7)
USA region
Northeast – Ref – Ref
Midwest – 0.8 (0.6, 1.1) – 1.0 (0.6, 1.7)
South – 0.8 (0.6, 1.1) – 1.1 (0.7, 1.8)
West – 1.1 (0.7, 1.5) – 1.8* (1.1, 2.9)
Perceived health status
Excellent – 0.6 (0.3, 1.4) – 0.3* (0.1, 0.9)
Very good – 0.7 (0.3, 1.3) – 0.6 (0.3, 1.2)
Good – 0.7 (0.4, 1.4) – 0.6 (0.3, 1.3)
Fair – 1.1 (0.5, 2.1) – 1.1 (0.5, 2.3)
Poor – Ref – Ref
Sexual orientation
Gay/lesbian/bisexual/Other – 1.4 (0.9, 2.1) – 1.1 (0.6, 1.9)
Heterosexual – Ref – Ref
Presence of children under
18 in the household
Yes – Ref – Ref
No – 1.1 (0.8, 1.4) – 0.8 (0.6, 1.2)
Model 1 included cigarette smoking status and other combustible and non-combustible tobacco use as predictors. Model 2 includes model 1
predictors, and demographic and health status covariates as statistical controls. Other combustible products include hookah, large cigars and little
cigars and cigarillos. Non-combustible products include snus, dissolvables and smokeless tobacco products. Current use was defined as use in the
previous 30 days, and ever (not current) use was defined as having ever used the product but not in the past 30 days
Boldface indicates statistical significance (p\ 0.05)
AOR adjusted odds ratio, CI confidence interval
* p\ 0.05, ** p\ 0.01, *** p\ 0.001
 30 % B RSE B 49 %
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The findings from the logistic regression models are
suggestive of high rates of dual use of ENDS and con-
ventional cigarettes. Of those who were current ENDS
users, 68.0 % were current cigarette smokers, 19.7 % were
recent former smokers (quit within past 5 years), 2.3 %
were non-recent former smokers (quit more than 5 years
ago), and 10.0 % were never cigarette smokers (Fig. 1).
Among current ENDS users, 21.0 % were current users of
any alternative combustible tobacco product (namely,
LCCs, large cigars, and/or hookah) and 75.1 % were cur-
rent users of any combustible tobacco product (namely,
LCCs, large cigars, hookah, and/or cigarettes).
Discussion
The findings of this study provide current data about the
awareness and use of ENDS and other novel tobacco
products. Of particular interest, an estimated 1 in 20 USA
adults, including 1 in 4 current cigarette smokers and 1 in
25 former smokers, were current ENDS users. These esti-
mates are more than two times higher than 2012/2013
national estimates reported in a recently published study
(King et al. 2015), although slightly lower than 2013
estimates from another study (McMillen et al. 2014). Of
the alternative tobacco products assessed, ENDS had the
highest prevalence of current use.
To a large degree, the observed patterns are being driven
by market forces rather than by public health. The tobacco
industry and the financial markets are noting that the
tobacco product markets are entering a period of poten-
tially dramatic product innovation and transformation
(Herzog et al. 2015; Philip Morris International 2015).
Published commentaries and editorials suggest that if
public policy encourages these changes, the tobacco epi-
demic could be transformed and dramatically reduced
(Abrams 2014; Cobb and Abrams 2014; Fagerstrom and
Bridgman 2014; West and Brown 2014). The 2014 Sur-
geon General report acknowledged that additional
‘‘endgame strategies’’ could be needed to avert the pro-
jected and sustained pattern of smoking-
attributable disease and premature death, but also noted,
based upon the history of past tobacco industry driven
product transformations, how the availability and promo-
tion of these new nicotine delivery products could be
projected either to reduce or increase population harm (US
Department of Health and Human Services 2014). This
potential impact that these products could have on popu-
lation health was recently estimated in a dynamic
population model (Vugrin et al. 2015). Recognizing that
there was significant uncertainty in defining and selecting
values for input parameters, the results showed how sen-
sitive the model results were to (1) tobacco-related health
risks of the various new and traditional products, (2) the
rates of initiation of traditional and new products, and (3)
the rates of switching and complete cessation, versus (4)
sustained dual use of the novel products along with tradi-







































Fig. 1 Tobacco product use among current users of electronic
nicotine delivery systems in the USA, 2014 (N = 316). Former
cigarette smokers were classified as recent former smokers if they
report last cigarette use within the past 5 years and as non-recent
former smokers if they reported last cigarette use more than 5 years
ago. The bars shaded in gray represent mutually exclusive and
exhaustive groups and sum to 100 % of current ENDS users. Current
users of any other combustible include those who reported past
30-day use of little cigars or cigarillos, large cigars, or hookah.
Current users of any combustible include those who reported any
combustible tobacco use in the past 30 days or current cigarette
smoking someday or everyday. Error bars depict 95 % confidence
intervals. RSE relative standard error. 30 % B RSE B 49 %
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The results from this 2014 Tobacco Products and Risk
Perceptions Survey and future annual surveys will provide
nationally representative parameter estimates to inform
such modeling of population harms. Specifically, the cur-
rent data provide details about the manner in which ENDS
are being combined (i.e., ‘‘dual use’’) not only with
cigarettes but with other combusted tobacco products.
These high rates of dual use merit close monitoring to see if
they could evolve into cessation of combusted tobacco
product use or sustained dual use that delays individuals
who would have quit tobacco products completely from
actually quitting (Chen and Husten 2014). Second, the fact
that almost one-third of the current ENDS users were ex-
smokers and never smokers also merits careful monitoring.
Of the 22.4 % of current ENDS users who were former
cigarette smokers, about one in ten were long-term (more
than 5 years) ex-smokers. This pattern raises concerns that
the current marketing and promotion of ENDS are con-
tributing to increased nicotine use and renormalization of
tobacco use. Future surveys need to monitor these patterns
to see if ex-smokers using ENDS are using them to prevent
relapse or if their re-initiation of nicotine use could lead to
relapsing back to combusted tobacco (McMillen et al.
2014).
This survey also shows that little cigars and cigarillos
(LCC) had the highest overall prevalence of ever use
among the alternative tobacco products, although this
ranking of prevalence did not hold across smoking status
subpopulations. Among smokeless products, chewing
tobacco/snuff/dip tobacco was most common and dissolv-
ables the least common in ever and current use. While the
risk of tobacco-related diseases is known to vary across
these products (US Department of Health and Human
Services 2014), the risks of cigars, particularly the little
cigars/cigarillos that are used and inhaled like cigarettes
may have risks as high or exceeding the risks from
smoking cigarettes (Chang et al. 2015). Thus, the data on
the patterns of the use of these individual novel or alter-
native tobacco products or their use in combination with
other combustible tobacco products can guide what addi-
tional evaluations of tobacco-related risk and risk
perceptions are most needed.
Limitations
This study has several limitations. First, the use of the
internet panel may raise concerns about sample represen-
tativeness, especially if the panel has been used in prior
tobacco research. Second, the data are based upon self-
report, and biochemical verification of cigarette smoking
and use of other products could not be conducted. While
the validity of self-reported cigarette smoking has been
confirmed (Caraballo et al. 2004; US Department of Health
and Human Services 2014), the accuracy of self-report of
other products, particularly the novel products, has not
been evaluated and remains uncertain. Third, due to the
rapidly changing nature of ENDS products being marketed
and used, how accurately the questionnaire descriptions
and terminology are assessing actual patterns of use is
continuing to be evaluated.
Conclusions
The results from this survey in conjunctions with other
published data highlight that the patterns of trial and use of
ENDS are evolving rapidly and merit continued surveil-
lance and study. Use of ENDS is more common among
current and former cigarette smokers, with patterns of use
of little cigars/cigarillos, hookah, large cigars, smokeless
tobacco, and ENDS varying significantly by sex, age, race/
ethnicity, education, income, perceived health status, and
sexual orientation. While use of ENDS primarily is com-
bined with cigarette smoking, more than one-tenth of
ENDS usage is among never cigarette smokers. Addition-
ally, the patterns of higher rates of dual use of ENDS and
combustible tobacco products among the less educated,
lower income, and those with poorer perceived health are
of concern. If these rates of dual use in these vulnerable
populations do not contribute to increased smoking cessa-
tion then, when combined with the continuing high rates of
use of all combusted tobacco products, these data raise
significant public health concerns that the growing preva-
lence of ENDS use could contribute to increased
population harm. Thus, this survey provides the FDA with
timely population-level data that may help inform FDA
policy development. Once FDA authority is properly
extended, this survey provides the agency with evidence to
inform product standards for novel nicotine products
appropriate for the protection of public health, a standard
specifically focused on evaluating product risk and benefit
at a population level (Chen and Husten 2014; Husten and
Deyton 2013).
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